Press release
Segmentation, Major Trends, and Competitive Overview of the Chronic Kidney Disease Market
The chronic kidney disease market is on the verge of significant expansion as healthcare advancements and growing patient awareness continue to drive demand. With increasing emphasis on early diagnosis and innovative treatments, this sector is set to experience noteworthy growth in the coming years. Let's explore the current market size, leading players, key trends, and segmentation details shaping the future of this healthcare niche.Forecasted Market Size and Growth Outlook for the Chronic Kidney Disease Market
The chronic kidney disease market is projected to reach $95.43 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.3%. This anticipated rise is fueled by a combination of factors including focused healthcare policies, advancements in precision medicine, increasing obesity rates, the prevalence of chronic illnesses, and improved accessibility to healthcare services. Important trends expected to influence the market during this period include widespread early screening initiatives, the adoption of telemedicine and remote patient monitoring, programs designed to empower patients, community-based care models, and the integration of nutritional therapies.
Download a free sample of the chronic kidney disease market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp
Leading Players Steering the Chronic Kidney Disease Market
Several prominent companies dominate the chronic kidney disease market. These include Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Mission Therapeutics Ltd., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, and ProKidney Corp.
AstraZeneca's Strategic Acquisition to Enhance Cardiorenal Portfolio
In a notable development during January 2023, AstraZeneca Pharmaceuticals LP acquired CinCor Pharma Inc. for $1.8 billion. This US-based biopharmaceutical company's acquisition brings CinCor's promising candidate, baxdrostat (CIN-107)-an aldosterone synthase inhibitor aimed at managing treatment-resistant hypertension-into AstraZeneca's cardiorenal pipeline. CinCor Pharma focuses on clinical-stage treatments for resistant hypertension and chronic kidney disease, enhancing AstraZeneca's position in these therapeutic areas.
View the full chronic kidney disease market report:
https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report
Innovation Trends Accelerating Market Growth in Chronic Kidney Disease
Product innovation stands out as a crucial driver for growth in the chronic kidney disease market. Companies continue to develop cutting-edge therapies to maintain competitive advantage. For example, in August 2022, Bayer introduced Kerendia (finerenone), a novel medication designed to slow chronic kidney disease progression in diabetic patients. This first-in-class non-steroidal, selective mineralocorticoid receptor antagonist functions differently from existing treatments by blocking mineralocorticoid receptor overactivation, which is linked to CKD advancement and cardiovascular complications.
Breaking Down the Chronic Kidney Disease Market Segmentation
This market is categorized across several key segments:
1) Diagnosis Methods: Blood Test, Urine Test, Imaging Test, Kidney Biopsy
2) Treatment Types: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments
3) Administration Routes: Oral, Intravenous, Subcutaneous
4) End-Users: Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users
Further detailed subsegments include:
- Blood Test types such as Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, and Electrolyte Tests
- Urine Test categories like Urinalysis, 24-hour Urine Collection, Urine Protein Test, and Urine Albumin-To-Creatinine Ratio (ACR)
- Imaging Test methods including Ultrasound, CT Scan, MRI, and X-ray
- Kidney Biopsy procedures categorized into Percutaneous Kidney Biopsy, Open Kidney Biopsy, and Laparoscopic Kidney Biopsy
This detailed segmentation helps provide a comprehensive understanding of the market's diverse diagnostic and treatment options, highlighting the scope for specialized care in chronic kidney disease management.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segmentation, Major Trends, and Competitive Overview of the Chronic Kidney Disease Market here
News-ID: 4328298 • Views: …
More Releases from The Business Research Company
Leading Companies Enhancing Their Presence in the Retail Clinics Market
The retail clinics sector is poised for significant expansion over the coming years, driven by advances in healthcare delivery and patient demand for accessible services. As consumers increasingly seek convenient options for primary care and minor treatments, this market is expected to evolve rapidly, fueled by innovation and growing health awareness. Here's a detailed look at the market's value projections, major players, emerging trends, and key segments shaping its future.
Expected…
Market Trend Analysis: The Impact of Recent Advances on the ACL Reconstruction P …
The ACL reconstruction procedures market is set to experience significant growth in the coming years, driven by technological advancements and increasing demand for improved surgical outcomes. This sector is evolving rapidly, with new innovations and expanding applications contributing to its promising outlook. Let's explore the market valuation, key players, emerging trends, and segmentation details shaping this industry.
Strong Growth Forecast for the ACL Reconstruction Procedures Market
The market for ACL reconstruction…
Future Perspectives: Key Trends Shaping the General Medical and Surgical Hospita …
The healthcare sector, particularly the general medical and surgical hospitals segment, is positioned for steady expansion in the coming years. Driven by evolving care models and technological advancements, this market is set to grow significantly. Below, we explore the market size, key players, influential trends, and detailed segmentation that define this important industry.
Projected Market Size and Growth Trajectory for General Medical and Surgical Hospitals
The general medical and surgical hospitals…
Revenue Cycle Management (RCM) Market Overview, Key Growth Factors, and Major Pl …
The revenue cycle management (RCM) industry is positioned for significant growth in the coming years, driven by advancements in technology and shifts in healthcare delivery models. As healthcare providers continue to seek efficient financial management solutions, the RCM market is evolving rapidly, offering exciting opportunities and innovations. Here's a detailed look at the market's size, key players, emerging trends, and segmentation.
Projected Market Value Expansion in the Revenue Cycle Management Market…
More Releases for Kidney
Chronic Kidney Diseases Fueling Kidney Stone Retrieval Device Growth Driving Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Kidney Stone Retrieval Devices Market Size By 2025?
In recent times, the market size for kidney stone retrieval devices has seen consistent growth. The market, which is projected to increase from $2.84 billion in 2024 to $2.96 billion in 2025, forecasts a compound annual growth…
Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and…
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key…
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook:
The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring…
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
